2011
DOI: 10.1371/journal.pone.0027632
|View full text |Cite
|
Sign up to set email alerts
|

Isoflurane-Induced Spatial Memory Impairment in Mice is Prevented by the Acetylcholinesterase Inhibitor Donepezil

Abstract: Although many studies have shown that isoflurane exposure impairs spatial memory in aged animals, there are no clinical treatments available to prevent this memory deficit. The anticholinergic properties of volatile anesthetics are a biologically plausible cause of cognitive dysfunction in elderly subjects. We hypothesized that pretreatment with the acetylcholinesterase inhibitor donepezil, which has been approved by the Food and Drug Administration (FDA) for the treatment of Alzheimer's disease, prevents isof… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
38
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 39 publications
(41 citation statements)
references
References 42 publications
2
38
0
Order By: Relevance
“…For example, chronic intragastric donepezil (5 mg/kg/day) had no effects on whole-brain AChE protein levels, but it did increase levels of choline acetyltransferase (ChAT), the rate-limiting enzyme for the synthesis of acetylcholine, and it reversed spatial learning deficits in aged mice. 54 Similarly, we reported an attenuation of CCI-induced ChAT( + ) medial septal cell loss at 3 weeks post-injury that correlated with improved cognitive performance. 40 Furthermore, Pike and Hamm showed an attenuation of fluid percussion (FP) injury-induced reduction of basal forebrain ChAT immunoreactivity after chronic administration of Lu 25-109-T, a partial M1 muscarinic receptor agonist and presynaptic M2 autoreceptor antagonist.…”
Section: Discussionsupporting
confidence: 54%
“…For example, chronic intragastric donepezil (5 mg/kg/day) had no effects on whole-brain AChE protein levels, but it did increase levels of choline acetyltransferase (ChAT), the rate-limiting enzyme for the synthesis of acetylcholine, and it reversed spatial learning deficits in aged mice. 54 Similarly, we reported an attenuation of CCI-induced ChAT( + ) medial septal cell loss at 3 weeks post-injury that correlated with improved cognitive performance. 40 Furthermore, Pike and Hamm showed an attenuation of fluid percussion (FP) injury-induced reduction of basal forebrain ChAT immunoreactivity after chronic administration of Lu 25-109-T, a partial M1 muscarinic receptor agonist and presynaptic M2 autoreceptor antagonist.…”
Section: Discussionsupporting
confidence: 54%
“…In fact, though spatial change detection implies efficient spatial mapping, novelty detection implies recognition of the salient object, thus minimizing the effect of the spatial and contextual factors [38,48,49]. Interestingly, the preserved abilities in detecting spatial change of Don-Sap rats reveal the specific neuroprotective effect of donepezil on a subtle spatial deficit induced by the cholinergic lesion and are in agreement with donepezil neuroprotective properties on spatial mnesic performances in different brain damage models [12-14,26,27]. …”
Section: Discussionmentioning
confidence: 84%
“…In contrast to the changes of proinflammatory cytokines, the tendency of increased apoptosis in the hippocampal CA1 region of the rats exposed to 1.3% isoflurane is in agreement with the impaired performance of these rats in the water maze test. Because hippocampal neuronal apoptosis [5,10,11,25], amyloid pathology [26], cholinergic dysfunction [27], and synaptic ultrastructure impairments [5,10,11,28], and so forth were postulated to be associated with isoflurane-induced cognitive dysfunction, the phenomenon may be caused by detrimental effects of isoflurane in the early phase, such as acute neuroinflammation, so that the previously mentioned events subsequently occur and lead to the delayed cognitive dysfunction.…”
Section: Discussionmentioning
confidence: 99%